Page last updated: 2024-11-10

h 409-22

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

H 409-22: a neuropeptide Y Y1 receptor antagonist; H 510-45 is the inactive enantiomer; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5311439
SCHEMBL ID1593464
MeSH IDM0378822

Synonyms (19)

Synonym
h 409-22
(2r)-5-(diaminomethylideneamino)-2-[(2,2-diphenylacetyl)amino]-n-[(1r)-1-(4-hydroxyphenyl)ethyl]pentanamide
SCHEMBL1593464
h-409/22
CS-7270
HY-101704
y1 receptor antagonist 1
h 409-22 isomer
221697-09-2
MS-29063
ar-h040922 freebase
7nck567ykq ,
n-((1r)-4-((aminoiminomethyl)amino)-1-((((1r)-1-(4-hydroxyphenyl)ethyl)amino)carbonyl)butyl)-alpha-phenylbenzeneacetamide
unii-7nck567ykq
benzeneacetamide, n-((1r)-4-((aminoiminomethyl)amino)-1-((((1r)-1-(4-hydroxyphenyl)ethyl)amino)carbonyl)butyl)-alpha-phenyl-
(2r)-2-((2,2-diphenylacetyl)amino)-5-guanidino-n-((1r)-1-(4-hydroxyphenyl)ethyl)pentanamide
benzeneacetamide, n-((1r)-4-((aminoiminomethyl)amino)-1-((((1r)-1-(4-hydroxyphenyl)ethyl)amino)carbonyl)butyl)-.alpha.-phenyl-
n-((1r)-4-((aminoiminomethyl)amino)-1-((((1r)-1-(4-hydroxyphenyl)ethyl)amino)carbonyl)butyl)-.alpha.-phenylbenzeneacetamide
AKOS040733811
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's8 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.83

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.83 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index5.14 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.83)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (12.50%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (87.50%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]